Navigation Links
TrialCheck(R) Cancer Clinical Trial Matching Interface to Debut on American Cancer Society Web Site
Date:9/10/2007

PHILADELPHIA, Sept. 10 /PRNewswire/ -- TrialCheck(R), the nation's premier searchable database for cancer clinical trials, debuts today at the American Cancer Society web site (http://www.cancer.org) and its 24-hour National Cancer Information Center (1-800-ACS-2345), giving millions of cancer patients quick access to clinical trial matches for their diagnosis and locale.

Developed by the Coalition of Cancer Cooperative Groups in 2001, TrialCheck uses a patient-centered approach to online clinical trials matching. Its disease-specific search filter guides users through a short query on a patient's type of cancer, treatment history and current condition (four to six questions). Its location-driven filter displays the search results by proximity to the user's zip code. As a result, users (patients and physicians) have tailored information on the thousands of nationally registered cancer clinical trials open and seeking patients in the United States.

The new TrialCheck service will give visitors to cancer.org the ability to pinpoint trials at specific providers near their desired locations. TrialCheck uses a simple, short questionnaire to provide accurate results and help patients identify appropriate clinical trials for their needs.

TrialCheck will also enable cancer.org users to link to trained clinical trial specialists at the Society's National Cancer Information Center directly from their TrialCheck search. Shared access enables Web visitors to get immediate assistance with their search, as well as guidance interpreting search results and help verifying hospitals and clinical practices where clinical trials are available.

All users receive a recap of their TrialCheck search in writing, sent via mail from the American Cancer Society. This packet of information, which includes summaries of protocols returned in search results, takes a critical step, facilitating communication between th
'/>"/>

SOURCE Coalition of Cancer Cooperative Groups
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
2. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
3. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
4. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
5. Protox Announces Positive Clinical Data from Prostate Cancer Study
6. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
7. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
8. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
9. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
10. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
11. Rosetta Genomics and Weizmann Institute Scientists Identify Role of microRNA in Cancer Suppression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... Calif. , May 28, 2015 Today, ... to check a state prescription database before prescribing the ... and thousands of overdose deaths. SB 482, ... Bell Gardens , will require prescribers to check ... before prescribing Schedule II and III drugs, like OxyContin ...
(Date:5/28/2015)... , May 28, 2015 National Community Pharmacists ... MBA issued the following statement in response to a ... Policy Institute documenting that a number of generic drug ... report tracks with concerns previously expressed by NCPA and ... patient access to essential medications. Moreover, a 2015 survey ...
(Date:5/28/2015)... INDIANAPOLIS , May 28, 2015   Eli Lilly ... INCY ) will host a webcast on June 11 ... studies of baricitinib in rheumatoid arthritis. Data from these two trials, ... the Scientific Programme for the EULAR Congress 2015 in ... be held from 10:00 to11:00 a.m. Eastern Daylight Time. The ...
Breaking Medicine Technology:California Senate Approves Legislation Requiring Physicians To Check State Database Before Prescribing Powerful, Addictive Medications, Says Consumer Watchdog 2NCPA: AARP Drug Pricing Report Reiterates Need for Fair Generic Drug Reimbursements 2Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase III Data 2Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase III Data 3
... U.S. Food and Drug Administration today approved Corifact, the ... the rare genetic defect congenital Factor XIII deficiency. ... with congenital Factor XIII deficiency don,t make enough Factor ... is important for normal clotting. Without treatment, people with ...
... Feb. 17, 2011 Georgia Health Sciences University, Augusta, ... 11th National Conference on Cancer Nursing Research in Los ... Technologies , zero displacement InVision-Plus® IV Connector ... by 92.6% on average when compared to a simple ...
Cached Medicine Technology:FDA Approves Product to Prevent Bleeding in People With Rare Genetic Defect 2New Clinical Study Shows RyMed InVision-Plus® IV Connector Dramatically Reduced Catheter-Related Bloodstream Infections by Over 92% 2New Clinical Study Shows RyMed InVision-Plus® IV Connector Dramatically Reduced Catheter-Related Bloodstream Infections by Over 92% 3
(Date:5/28/2015)... AMVETS leaders this week congratulated AMVETS 2015 Memorial ... Newark, Del. AMVETS National Commander Larry Via personally called ... sweepstakes grand prize. , AMVETS selected the 10 lucky ... country for prizes ranging from $500 to the $10,000 ... at the AMVETS National Headquarters in Lanham, MD. , ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 Are policies ... after a hospital stay triggering financial pain for seniors? ... American Journal of Managed Care set to figure out, ... recent federal rule change. , The study, “Observation Encounters ... A. Vashi, MD, MPH, examined how Medicare policies that ...
(Date:5/28/2015)... Florida (PRWEB) May 28, 2015 Ross ... plastic surgeon , has hired Teresa Beard as the ... In her role, Beard will oversee all marketing and ... years of experience leading teams and developing compelling marketing ... Face and Body Specialists, Beard served as guest communication ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 Medelis, Inc., a ... has joined the company in the role of president. , ... leadership in the CRO industry,” said Larry Flanagan, Medelis’ CEO ... the company through our next phase of growth.” , ... its growth from nine employees to over 4,500 employees, achieving ...
(Date:5/28/2015)... As the summer approaches, many people will head to the ... safety a top priority, however, and that’s why Amica ... the Centers for Disease Control, 10 people die from drowning ... Additionally, the National Safety Council says drowning is the leading ... , Amica is sharing the following tips from the American ...
Breaking Medicine News(10 mins):Health News:AMVETS Announces Summer Sweepstakes Winners 2Health News:AJMC Study Examines Effect of Medicare Rules on Care After Hospital Observation 2Health News:AJMC Study Examines Effect of Medicare Rules on Care After Hospital Observation 3Health News:Clevens Face and Body Specialists Welcomes Teresa Beard as Marketing Director 2Health News:Bill Taaffe, Former President and CEO of ICON Clinical Research-US, Joins Medelis, a Specialty Oncology CRO, in the Role of President 2Health News:Splash! Amica Shares 6 Swimming Safety Tips 2
... small amount in neck artery quadrupled the risk, study found ... even a small amount of plaque build-up in their carotid ... -- are up to four times more likely to suffer ... arteries, a new study finds. , "These results are important ...
... Idol,s Fight against Malaria, NEW YORK, March 19 ... airing Wednesday, April 9 (7:30-10:00 PM,ET/PT) on FOX, will raise ... year in a row as part of its star-studded event., ... named a beneficiary of Idol,Gives Back, which last year raised ...
... YORK, March 19 More than 90% of ... due to the lack of,effectiveness or adverse side ... could be avoided with pre-clinical tests using stem ... Information,s new report Stem Cells: Worldwide Markets for,Transplantation, ...
... QED International Associates Inc.,administrator for the HealthShares(TM) Indexes, a ... today announced the,quarterly rebalancing of the Indexes., The ... Indexes,effective before the opening of trading on NYSE Arca ... Drop GW Pharmaceuticals, Inc (LSE: GWP.L) ...
... March 19, 2008 The Russell Berrie Foundation has ... NewYork-Presbyterian Hospital, as part of a focused effort to ... concentrated research initiatives, toward a cure, the Medical Center ... killer, diabetes is a disease in which the bodys ...
... LAUSANNE, Switzerland, March 19 Galderma Pharma S.A., ... that its U.S. holding company, Galderma Laboratories, Inc., ... through the,expiration of the required waiting period under ... of CollaGenex,(Nasdaq: CGPI )., "We are ...
Cached Medicine News:Health News:Artery Plaque Boosts Hispanics' Odds for Stroke 2Health News:American Idol Spotlights Malaria Crisis During Idol Gives Back, April 9, On FOX 2Health News:Stem Cell Technology Offers Promise of Huge Savings for Drug Developers 2Health News:QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes 2Health News:QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes 3Health News:QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes 4Health News:QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes 5Health News:QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes 6Health News:QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes 7Health News:QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes 8Health News:QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes 9Health News:QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes 10Health News:QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes 11Health News:QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes 12Health News:QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes 13Health News:QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes 14Health News:QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes 15Health News:Columbia University Medical Center/NYPH receive $28 million donation toward curing diabetes 2Health News:Columbia University Medical Center/NYPH receive $28 million donation toward curing diabetes 3Health News:Galderma Announces HSR Clearance for Its Proposal to Acquire CollaGenex Pharmaceuticals 2Health News:Galderma Announces HSR Clearance for Its Proposal to Acquire CollaGenex Pharmaceuticals 3Health News:Galderma Announces HSR Clearance for Its Proposal to Acquire CollaGenex Pharmaceuticals 4Health News:Galderma Announces HSR Clearance for Its Proposal to Acquire CollaGenex Pharmaceuticals 5
The Skull Pins are inserted into the receptacles of the Skull Clamp and fixate the head during surgery....
... designed for rigid skeletal fixation, ... freedom in positioning the fixation ... fixation is designed for the ... positions. Craniotomies can be performed ...
... rigid endoscopes for general applications and are equipped ... of borescopes, i.e. rigid endoscopes, range between 1 ... 0 up to a 120 retrospection, and image ... angle view. Endoscopes with working lengths of 1.5 ...
... Design for Neurosurgery. The Neuroview ... working channel scopes with a ... scope body facilitates a direct, ... The steerable tip allows access ...
Medicine Products: